Keywords
Last Name
Institution

F. BLAINE HOLLINGER

TitleProfessor
InstitutionBaylor College of Medicine
DepartmentDepartment of Molecular Virology & Microbiology
DivisionMolecular Virology & Microbiology
AddressOne Baylor Plaza
Houston TX 77030
vCardDownload vCard
    Other Positions
    TitleProfessor
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Medicine
    DivisionMedicine-Gastroenterology & Hepatol


    Collapse Additional Tools and Researcher Information 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Khaderi SA, Hollinger FB. Is the Risk of Death Enhanced in Immunosuppressed HBV-Infected Patients Who Develop Acute Liver Failure? Clin Gastroenterol Hepatol. 2016 Sep 27. PMID: 27693523.
      View in: PubMed
    2. Hollinger FB. Should Evidence-based Medicine Be Used to Design Clinical Practice Guidelines for the Prevention of Perinatal Transmission of Hepatitis B Virus From Hepatitis B e Antigen-Positive Mothers? Clin Gastroenterol Hepatol. 2015 Jun; 13(6):1177-80. PMID: 25701701.
      View in: PubMed
    3. Tansel A, Kanwal F, Hollinger FB. Use of Hy's Law, R criteria, and nR criteria to predict acute liver failure or transplantation in patients with drug-induced liver injury. Gastroenterology. 2015 Feb; 148(2):452. PMID: 25532807.
      View in: PubMed
    4. Huang X, Qin Y, Li W, Shi Q, Xue Y, Li J, Liu C, Hollinger FB, Shen Q. Molecular analysis of the hepatitis B virus presurface and surface gene in patients from eastern China with occult hepatitis B. J Med Virol. 2013 Jun; 85(6):979-86. PMID: 23588723.
      View in: PubMed
    5. Das GC, Hollinger FB. Molecular pathways for glucose homeostasis, insulin signaling and autophagy in hepatitis C virus induced insulin resistance in a cellular model. Virology. 2012 Dec 5; 434(1):5-17. PMID: 22862962.
      View in: PubMed
    6. Stramer SL, Wend U, Candotti D, Foster GA, Hollinger FB, Dodd RY, Allain JP, Gerlich W. Nucleic acid testing to detect HBV infection in blood donors. N Engl J Med. 2011 Jan 20; 364(3):236-47. PMID: 21247314.
      View in: PubMed
    7. Klein HG, Dodd RY, Hollinger FB, Katz LM, Kleinman S, McCleary KK, Silverman RH, Stramer SL. Xenotropic murine leukemia virus-related virus (XMRV) and blood transfusion: report of the AABB interorganizational XMRV task force. Transfusion. 2011 Mar; 51(3):654-61. PMID: 21235597.
      View in: PubMed
    8. Hollinger FB, Sood G. Occult hepatitis B virus infection: a covert operation. J Viral Hepat. 2010 Jan; 17(1):1-15. PMID: 20002296.
      View in: PubMed
    9. Stramer SL, Hollinger FB, Katz LM, Kleinman S, Metzel PS, Gregory KR, Dodd RY. Emerging infectious disease agents and their potential threat to transfusion safety. Transfusion. 2009 Aug; 49 Suppl 2:1S-29S. PMID: 19686562.
      View in: PubMed
    10. Hollinger FB, Dodd RY. Hepatitis B virus traceback and lookback: factors to consider. Transfusion. 2009 Jan; 49(1):176-84. PMID: 19140810.
      View in: PubMed
    11. Hollinger FB. Hepatitis B virus infection and transfusion medicine: science and the occult. Transfusion. 2008 May; 48(5):1001-26. PMID: 18454738.
      View in: PubMed
    12. Hollinger FB. Hepatitis B virus genetic diversity and its impact on diagnostic assays. J Viral Hepat. 2007 Nov; 14 Suppl 1:11-5. PMID: 17958637.
      View in: PubMed
    13. Hollinger FB, Bell B, Levy-Bruhl D, Shouval D, Wiersma S, Van Damme P. Hepatitis A and B vaccination and public health. J Viral Hepat. 2007 Nov; 14 Suppl 1:1-5. PMID: 17958635.
      View in: PubMed
    14. Carr C, Hollinger FB, Yoffe B, Wakil A, Phillips J, Bzowej N, Leung J, Mirro K, Poordad F, Moore DH, Gish RG. Efficacy of interferon alpha-2b induction therapy before retreatment for chronic hepatitis C. Liver Int. 2007 Oct; 27(8):1111-8. PMID: 17845540.
      View in: PubMed
    15. Nurgalieva ZZ, Hollinger FB, Graham DY, Zhangabylova S, Zhangabylov A. Epidemiology and transmission of hepatitis B and C viruses in Kazakhstan. World J Gastroenterol. 2007 Feb 28; 13(8):1204-7. PMID: 17451200; PMCID: PMC4146994.
    16. Hollinger FB, Lau DT. Hepatitis B: the pathway to recovery through treatment. Gastroenterol Clin North Am. 2006 Jun; 35(2):425-61, x. PMID: 16880074.
      View in: PubMed
    17. Keasler VV, Lerat H, Madden CR, Finegold MJ, McGarvey MJ, Mohammed EM, Forbes SJ, Lemon SM, Hadsell DL, Grona SJ, Hollinger FB, Slagle BL. Increased liver pathology in hepatitis C virus transgenic mice expressing the hepatitis B virus X protein. Virology. 2006 Apr 10; 347(2):466-75. PMID: 16427673.
      View in: PubMed
    18. Soucie JM, Siwak EB, Hooper WC, Evatt BL, Hollinger FB. Human parvovirus B19 in young male patients with hemophilia A: associations with treatment product exposure and joint range-of-motion limitation. Transfusion. 2004 Aug; 44(8):1179-85. PMID: 15265122.
      View in: PubMed
    19. Lerat H, Hollinger FB. Hepatitis C virus (HCV) occult infection or occult HCV RNA detection? J Infect Dis. 2004 Jan 1; 189(1):3-6. PMID: 14702146.
      View in: PubMed
    20. Hollinger FB, Kleinman S. Transfusion transmission of West Nile virus: a merging of historical and contemporary perspectives. Transfusion. 2003 Aug; 43(8):992-7. PMID: 12869102.
      View in: PubMed
    21. Nurgalieva ZZ, Malaty HM, Graham DY, Almuchambetova R, Machmudova A, Kapsultanova D, Osato MS, Hollinger FB, Zhangabylov A. Helicobacter pylori infection in Kazakhstan: effect of water source and household hygiene. Am J Trop Med Hyg. 2002 Aug; 67(2):201-6. PMID: 12389948.
      View in: PubMed
    22. LaRussa P, Magder LS, Pitt J, Sill A, Hillyer G, Hollinger FB, Lew J, McIntosh K, Kufera J, Bremer J, Blattner W. Association of HIV-1 viral phenotype in the MT-2 assay with perinatal HIV transmission. J Acquir Immune Defic Syndr. 2002 May 1; 30(1):88-94. PMID: 12048368.
      View in: PubMed
    23. Lin HJ, Seeff LB, Barbosa L, Hollinger FB. Occurrence of identical hypervariable region 1 sequences of hepatitis C virus in transfusion recipients and their respective blood donors: divergence over time. Hepatology. 2001 Aug; 34(2):424-9. PMID: 11481629.
      View in: PubMed
    24. Lin HJ, Siwak EB, Lauder IJ, Hollinger FB. Long-term culture of human immunodeficiency virus type 1 resulting in loss of glycosylation sites. J Med Virol. 2001 Mar; 63(3):197-202. PMID: 11170057.
      View in: PubMed
    25. Hollinger FB. Factors contributing to the evolution and outcome of cirrhosis in hepatitis C. Clin Liver Dis. 1999 Nov; 3(4):741-55, viii. PMID: 11291248.
      View in: PubMed
    26. Lin HJ, Siwak EB, Lauder IJ, Hollinger FB. Selection of appropriate HIV-1 genomic regions for single-strand conformation polymorphism analysis of the diversity, modification, and transmission of HIV-1 quasispecies. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Aug 15; 18(5):409-16. PMID: 9715836.
      View in: PubMed
    27. Lin HJ, Pedneault L, Hollinger FB. Intra-assay performance characteristics of five assays for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol. 1998 Mar; 36(3):835-9. PMID: 9508327; PMCID: PMC104640.
    28. Hollinger FB. Overview of viral hepatitis. Int J Circumpolar Health. 1998; 57 Suppl 1:276-9. PMID: 10093289.
      View in: PubMed
    29. Troisi CL, Hollinger FB, Krause DS, Pickering LK. Immunization of seronegative infants with hepatitis A vaccine (HAVRIX; SKB): a comparative study of two dosing schedules. Vaccine. 1997 Oct; 15(15):1613-7. PMID: 9364691.
      View in: PubMed
    30. Troisi CL, Hollinger FB. Detection of antibodies to hepatitis C virus in seronegative patients using an immune complex dissociation assay. J Viral Hepat. 1997; 4(6):383-6. PMID: 9430358.
      View in: PubMed
    31. Lin HJ, Tanwandee T, Hollinger FB. Improved methods for quantification of human immunodeficiency virus type 1 RNA and hepatitis C virus RNA in blood using spin column technology and chemiluminescent assays of PCR products. J Med Virol. 1997 Jan; 51(1):56-63. PMID: 8986950.
      View in: PubMed
    32. Lin HJ, Haywood M, Hollinger FB. Application of a commercial kit for detection of PCR products to quantification of human immunodeficiency virus type 1 RNA and proviral DNA. J Clin Microbiol. 1996 Feb; 34(2):329-33. PMID: 8789009; PMCID: PMC228791.
    33. Hollinger FB. Comprehensive control (or elimination) of hepatitis B virus transmission in the United States. Gut. 1996; 38 Suppl 2:S24-30. PMID: 8786049; PMCID: PMC1398039.
    34. Qavi HB, Green MT, Lewis DE, Hollinger FB, Pearson G, Ablashi DV. HIV-1 and HHV-6 antigens and transcripts in retinas of patients with AIDS in the absence of human cytomegalovirus. Invest Ophthalmol Vis Sci. 1995 Sep; 36(10):2040-7. PMID: 7657542.
      View in: PubMed
    35. Lin HJ, Siwak EB, Lauder IJ, Hollinger FB. Single-strand conformation polymorphism study of human immunodeficiency virus type 1 RNA and DNA in plasma, peripheral blood mononuclear cells, and their virologic cultures. J Infect Dis. 1995 Jun; 171(6):1619-22. PMID: 7769303.
      View in: PubMed
    36. Hollinger FB, Mouneimne Y, Lahart C, Tosi PF, Dimitrov D, Nicolau C. Life span of circulating membrane CD4 inserted into the plasma membranes of autologous red blood cells of HIV-infected subjects. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Jun 1; 9(2):126-32. PMID: 7749788.
      View in: PubMed
    37. Hollinger FB, Eickhoff T, Gershon A, Jong EC, Koff RS. Discussion: who should receive hepatitis A vaccine? A strategy for controlling hepatitis A in the United States. J Infect Dis. 1995 Mar; 171 Suppl 1:S73-7. PMID: 7876653.
      View in: PubMed
    38. Lewis DE, Adu-Oppong A, Hollinger FB, Rosenblatt HM, Hanson IC, Reuben JM, Kline MW, Kozinetz CA, Shearer WT. Sensitivity of immune complex-dissociated p24 antigen testing for early detection of human immunodeficiency virus in infants. Clin Diagn Lab Immunol. 1995 Jan; 2(1):87-90. PMID: 7719918; PMCID: PMC170106.
    39. Lin HJ, Myers LE, Yen-Lieberman B, Hollinger FB, Henrard D, Hooper CJ, Kokka R, Kwok S, Rasheed S, Vahey M, et al. Multicenter evaluation of quantification methods for plasma human immunodeficiency virus type 1 RNA. J Infect Dis. 1994 Sep; 170(3):553-62. PMID: 7915748.
      View in: PubMed
    40. Kline MW, Lewis DE, Hollinger FB, Reuben JM, Hanson LC, Kozinetz CA, Dimitrov DH, Rosenblatt HM, Shearer WT. A comparative study of human immunodeficiency virus culture, polymerase chain reaction and anti-human immunodeficiency virus immunoglobulin A antibody detection in the diagnosis during early infancy of vertically acquired human immunodeficiency virus infection. Pediatr Infect Dis J. 1994 Feb; 13(2):90-4. PMID: 8190557.
      View in: PubMed
    41. Han KH, Hollinger FB, Noonan CA, Solomon H, Klintmalm GB, Genta RM, Yoffe B. Southern-blot analysis and simultaneous in situ detection of hepatitis B virus-associated DNA and antigens in patients with end-stage liver disease. Hepatology. 1993 Nov; 18(5):1032-8. PMID: 8225208.
      View in: PubMed
    42. Lin HJ, Lau JY, Lauder IJ, Shi N, Lai CL, Hollinger FB. The hepatitis C virus genome: a guide to its conserved sequences and candidate epitopes. Virus Res. 1993 Oct; 30(1):27-41. PMID: 7505514.
      View in: PubMed
    43. Dimitrov DH, Hollinger FB, Baker CJ, Kline MW, Doyle M, Bremer JW, Shearer WT. Study of human immunodeficiency virus resistance to 2'-3'-dideoxyinosine and zidovudine in sequential isolates from pediatric patients on long-term therapy. J Infect Dis. 1993 Apr; 167(4):818-23. PMID: 8450246.
      View in: PubMed
    44. Troisi CL, Hollinger FB, Hoots WK, Contant C, Gill J, Ragni M, Parmley R, Sexauer C, Gomperts E, Buchanan G, et al. A multicenter study of viral hepatitis in a United States hemophilic population. Blood. 1993 Jan 15; 81(2):412-8. PMID: 7678517.
      View in: PubMed
    45. Kline MW, Hollinger FB, Rosenblatt HM, Bohannon B, Kozinetz CA, Shearer WT. Sensitivity, specificity and predictive value of physical examination, culture and other laboratory studies in the diagnosis during early infancy of vertically acquired human immunodeficiency virus infection. Pediatr Infect Dis J. 1993 Jan; 12(1):33-6. PMID: 8417423.
      View in: PubMed
    46. Lin HJ, Shi N, Mizokami M, Hollinger FB. Polymerase chain reaction assay for hepatitis C virus RNA using a single tube for reverse transcription and serial rounds of amplification with nested primer pairs. J Med Virol. 1992 Nov; 38(3):220-5. PMID: 1337550.
      View in: PubMed
    47. Mathur S, Verseman S, Estrada R, Hollinger FB. Bleeding from a Meckel's diverticulum after the use of ibuprofen. Am J Gastroenterol. 1992 Oct; 87(10):1467-70. PMID: 1415106.
      View in: PubMed
    48. Qavi HB, Green MT, SeGall GK, Lewis DE, Hollinger FB. Transcriptional activity of HIV-1 and HHV-6 in retinal lesions from AIDS patients. Invest Ophthalmol Vis Sci. 1992 Sep; 33(10):2759-67. PMID: 1326493.
      View in: PubMed
    49. Hollinger FB, Bremer JW, Myers LE, Gold JW, McQuay L. Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS Clinical Trials Group. The NIH/NIAID/DAIDS/ACTG Virology Laboratories. J Clin Microbiol. 1992 Jul; 30(7):1787-94. PMID: 1629336; PMCID: PMC265382.
    50. Qavi HB, Green MT, SeGall GK, Lewis DE, Hollinger FB. Frequency of dual infections of corneas with HIV-1 and HHV-6. Curr Eye Res. 1992 Apr; 11(4):315-23. PMID: 1326427.
      View in: PubMed
    51. Han KH, Hollinger FB, Noonan CA, Yoffe B. Simultaneous detection of HBV-specific antigens and DNA in paraffin-embedded liver tissue by immunohistochemistry and in situ hybridization using a digoxigenin-labeled probe. J Virol Methods. 1992 Apr; 37(1):89-97. PMID: 1572934.
      View in: PubMed
    52. Qavi HB, Green MT, SeGall GK, Hollinger FB, Lewis DE. The incidence of HIV-1 and HHV-6 in corneal buttons. Curr Eye Res. 1991; 10 Suppl:97-103. PMID: 1650678.
      View in: PubMed
    53. Dimitrov DH, Melnick JL, Hollinger FB. Microculture assay for isolation of human immunodeficiency virus type 1 and for titration of infected peripheral blood mononuclear cells. J Clin Microbiol. 1990 Apr; 28(4):734-7. PMID: 2332470; PMCID: PMC267785.
    54. Hollinger FB. Controlling hepatitis B virus transmission in North America. The North American Regional Study Group. Vaccine. 1990 Mar; 8 Suppl:S122-8; discussion S134-8. PMID: 2139279.
      View in: PubMed
    55. Hollinger FB. Factors influencing the immune response to hepatitis B vaccine, booster dose guidelines, and vaccine protocol recommendations. Am J Med. 1989 Sep 4; 87(3A):36S-40S. PMID: 2528297.
      View in: PubMed
    56. Yoffe B, Petrie BL, Noonan CA, Hollinger FB. In vivo and in vitro ultrastructural alterations induced by human immunodeficiency virus in human lymphoid cells. Lab Invest. 1989 Sep; 61(3):303-9. PMID: 2570180.
      View in: PubMed
    57. Garcia G, Hollinger FB. Hepatitis B virus infection and renal transplantation. Hepatology. 1988 Sep-Oct; 8(5):1172-4. PMID: 3047040.
      View in: PubMed
    HOLLINGER's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _